Tang D - Search Results

1

Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell Carcinoma.

Cao X, Tang D, Ratto B, Poole A, Ravichandran S, Jin L, Gao W, Swallow E, Vogelzang NJ. Cao X, et al. Among authors: tang d. Clin Genitourin Cancer. 2020 Feb;18(1):e37-e45. doi: 10.1016/j.clgc.2019.10.010. Epub 2019 Oct 16. Clin Genitourin Cancer. 2020. PMID: 31727510

2

Progression-free Survival With First-line Endocrine-based Therapies Among Postmenopausal Women With HR+/HER2- Metastatic Breast Cancer:: A Network Meta-analysis.

Ayyagari R, Tang D, Patterson-Lomba O, Zhou Z, Xie J, Chandiwana D, Dalal AA, Niravath PA. Ayyagari R, et al. Among authors: tang d. Clin Ther. 2018 Apr;40(4):628-639.e3. doi: 10.1016/j.clinthera.2018.03.004. Epub 2018 Mar 31. Clin Ther. 2018. PMID: 29609880

3

Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2- advanced or metastatic breast cancer.

Mistry R, Suri G, Young K, Hettle R, May JR, Brixner D, Oderda G, Biskupiak J, Tang D, Bhattacharyya D, Bhattacharyya S, Mishra D, Dalal AA. Mistry R, et al. Among authors: tang d. Curr Med Res Opin. 2018 Dec;34(12):2143-2150. doi: 10.1080/03007995.2018.1503484. Epub 2018 Aug 17. Curr Med Res Opin. 2018. PMID: 30032697

4

Real-world palbociclib dosing patterns and implications for drug costs in the treatment of HR+/HER2- metastatic breast cancer.

Li N, Du EX, Chu L, Peeples M, Xie J, Barghout V, Tang DH. Li N, et al. Expert Opin Pharmacother. 2017 Aug;18(12):1167-1178. doi: 10.1080/14656566.2017.1351947. Epub 2017 Jul 19. Expert Opin Pharmacother. 2017. PMID: 28699804

5

First-line treatment disruption among post-menopausal women with HR+/HER2- metastatic breast cancer: a retrospective US claims study.

Tang DH, Li N, Du EX, Peeples M, Chu L, Xie J, Barghout V. Tang DH, et al. Curr Med Res Opin. 2017 Dec;33(12):2137-2143. doi: 10.1080/03007995.2017.1390447. Epub 2017 Oct 27. Curr Med Res Opin. 2017. PMID: 28994315

6

Progression-free survival with endocrine-based therapies following progression on non-steroidal aromatase inhibitor among postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative metastatic breast cancer: a network meta-analysis.

Ayyagari R, Tang D, Patterson-Lomba O, Zhou Z, Xie J, Chandiwana D, Dalal AA, Niravath PA. Ayyagari R, et al. Among authors: tang d. Curr Med Res Opin. 2018 Sep;34(9):1645-1652. doi: 10.1080/03007995.2018.1479246. Epub 2018 Jun 12. Curr Med Res Opin. 2018. PMID: 29781326

7

Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with Targeted Therapy on Quality of Life of Postmenopausal Women with HR+/HER2- Advanced Breast Cancer.

Zhou Z, Tang DH, Xie J, Ayyagari R, Wu E, Niravath PA. Zhou Z, et al. Adv Ther. 2017 Dec;34(12):2566-2584. doi: 10.1007/s12325-017-0644-2. Epub 2017 Nov 16. Adv Ther. 2017. PMID: 29143928 Review.

8

Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States.

Seiter K, Latremouille-Viau D, Guerin A, Ndife B, Habucky K, Tang DH, Pivneva I, Gagnon-Sanschagrin P, Joseph GJ. Seiter K, et al. Among authors: tang dh. Adv Ther. 2018 Oct;35(10):1671-1685. doi: 10.1007/s12325-018-0772-3. Epub 2018 Aug 28. Adv Ther. 2018. PMID: 30155792

9

Predictors of systemic therapy sequences following a CDK 4/6 inhibitor-based regimen in post-menopausal women with hormone receptor positive, HEGFR-2 negative metastatic breast cancer.

Princic N, Aizer A, Tang DH, Smith DM, Johnson W, Bardia A. Princic N, et al. Curr Med Res Opin. 2019 Jan;35(1):73-80. doi: 10.1080/03007995.2018.1519500. Epub 2018 Sep 20. Curr Med Res Opin. 2019. PMID: 30175631

10

Treatment patterns and factors associated with the use of everolimus among post-menopausal women with HR+/HER2- metastatic breast cancer: a retrospective US claims study.

Guérin A, Hao Y, Tang D, Peeples M, Fang A, Kageleiry A, Koo V, Li N, Wu EQ. Guérin A, et al. Among authors: tang d. Expert Opin Pharmacother. 2016 Jun;17(9):1189-96. doi: 10.1080/14656566.2016.1176148. Epub 2016 Apr 21. Expert Opin Pharmacother. 2016. PMID: 27052735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,103 results

Search Page

Filters